Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

FTSE 250 movers: Vistry surges, Syncona sinks on write-off

Published 11/09/2023, 16:39
© Reuters.  FTSE 250 movers: Vistry surges, Syncona sinks on write-off

Sharecast - The UK home builder on Monday said it was now aiming for return on capital employed of 40%, revenue growth of 5 – 8% a year and operating profit of £800m with an operating margin of at least 12%.

"The scale of the social need for affordable mixed tenure housing across the country continues to increase and it is clear that Vistry is uniquely positioned as the leader in partnerships housing," said chief executive Greg Fitzgerald.

Vistry posted an 8.4% fall in adjusted half-year pre-tax profits to £174m amid a tough housing market where prices have been falling in response to higher mortgage costs.

Half-year underlying revenue rose 31.4% to £1.8bn, while underlying operating profit was £206.7m, up 4.3%. Meanwhile Vistry's net debt position was £328.7m, compared to net cash of £118.2 at the end of last year, and the company maintained underlying pre-tax profit guidance for the full year of more than £450m.

"It's fair to say the housebuilding division’s been stuttering lately. Recent interest rate rises have reduced affordability for buyers, causing private sales rates to decline and completions to be wound lower as a result," said Aarin Chiekrie, equity analyst at Hargreaves Lansdown (LON:HRGV).

"That’s no surprise though, given housebuilding’s a notoriously cyclical sector. In contrast, Partnerships’ revenues tend to be more robust - the need for more affordable housing doesn’t go away because economic conditions look tough. This provides large fixed-volume projects which should hold up better in a downturn."

Syncona shares fell as the British healthcare investment firm said Novartis (LON:0QLR) had stopped the development of experimental eye treatment, GT005, which would result in a milestone payments write-off of £54.5m for Gyroscope Holdings Limited in which Syncona had a 54% stake.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Gyroscope was sold to Novartis in February last year in a $1.5bn deal, with Syncona receiving $442m for its stake.

Market Movers

FTSE 250 (MCX) 18,501.26 0.21%

FTSE 250 - Risers

Vistry Group (LON:VTYV) (VTY) 915.00p 14.38%

Babcock International Group (LON:BAB) 396.60p 3.34%

Hipgnosis Songs Fund Limited NPV (SONG) 94.80p 2.71%

Petershill Partners (PHLL) 154.00p 2.67%

TUI (LON:TUIT) AG Reg Shs (DI) (TUI) 476.80p 2.58%

Vanquis Banking Group 20 (VANQ) 120.00p 2.56%

Me Group International (MEGP) 161.00p 2.55%

Jupiter Fund Management (JUP) 95.85p 2.51%

Molten Ventures (GROW) 246.40p 2.24%

HGCapital Trust (HGT) 397.00p 2.06%

FTSE 250 - Fallers

Syncona Limited NPV (SYNC) 120.20p -6.09%

W.A.G Payment Solutions (WPS) 86.20p -5.27%

Direct Line Insurance Group (DLG) 175.45p -3.33%

Baltic Classifieds Group (BCG) 192.40p -3.02%

Wizz Air Holdings (LON:WIZZ) 1,988.50p -2.72%

Playtech (LON:PTEC) 517.50p -2.54%

NCC Group (NCC) 94.50p -2.07%

Indivior (INDV) 1,801.00p -1.91%

Senior (SNR) 172.60p -1.71%

Bakkavor Group (BAKK) 99.40p -1.58%

Read more on Sharecast.com

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.